NEUCA S.A. (WSE:NEU)

Poland flag Poland · Delayed Price · Currency is PLN
712.00
-17.00 (-2.33%)
Apr 28, 2026, 5:00 PM CET
3.64%
Market Cap 3.28B
Revenue (ttm) 13.64B
Net Income (ttm) 155.58M
Shares Out 4.51M
EPS (ttm) 34.05
PE Ratio 21.41
Forward PE 17.15
Dividend 17.80 (2.44%)
Ex-Dividend Date Jul 15, 2025
Volume 1,095
Average Volume 2,269
Open 731.00
Previous Close 729.00
Day's Range 702.00 - 732.00
52-Week Range 645.00 - 857.00
Beta 0.44
RSI 51.80
Earnings Date May 21, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p... [Read more]

Sector Healthcare
Founded 1990
Employees 4,445
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NEU
Full Company Profile

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Financial Statements

News

There is no news available yet.